Loading…

Synthesis and biological activity evaluation of lignan lactones derived from (−)-cubebin

The anti-inflammatory and analgesic activities of three dibenzylbutyrolactone lignans obtained by partial synthesis starting from (−)-cubebin ( 1), which was isolated from the seeds of Piper cubeba, were evaluated using different animal models. The anti-inflammatory and analgesic effects of three di...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry letters 2005-02, Vol.15 (4), p.1033-1037
Main Authors: Silva, Rosangela da, de Souza, Gustavo H.B., da Silva, Ademar A., de Souza, Vanessa A., Pereira, Ana C., Royo, Vanesa de A., e Silva, Marcio L.A., Donate, Paulo M., de Matos Araújo, Ana L.S., Carvalho, José C.T., Bastos, Jairo K.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c384t-c2aceba8478c43025b12fab453df6867435ae4fce876a19b3de52a4e0a630db3
cites cdi_FETCH-LOGICAL-c384t-c2aceba8478c43025b12fab453df6867435ae4fce876a19b3de52a4e0a630db3
container_end_page 1037
container_issue 4
container_start_page 1033
container_title Bioorganic & medicinal chemistry letters
container_volume 15
creator Silva, Rosangela da
de Souza, Gustavo H.B.
da Silva, Ademar A.
de Souza, Vanessa A.
Pereira, Ana C.
Royo, Vanesa de A.
e Silva, Marcio L.A.
Donate, Paulo M.
de Matos Araújo, Ana L.S.
Carvalho, José C.T.
Bastos, Jairo K.
description The anti-inflammatory and analgesic activities of three dibenzylbutyrolactone lignans obtained by partial synthesis starting from (−)-cubebin ( 1), which was isolated from the seeds of Piper cubeba, were evaluated using different animal models. The anti-inflammatory and analgesic effects of three dibenzylbutyrolactone lignans, (−)-hinokinin ( 2), (−)-6,6′-dinitrohinokinin ( 3), and (−)-6,6′-diaminohinokinin ( 4), obtained by partial synthesis from (−)-cubebin ( 1), were investigated using different animal models. It was observed that compounds ( 1) and ( 2) inhibited the edema formation in the rat paw edema assay at the same level and that all responses were dose dependent. Also, at the dose of 30 mg/kg, compounds 1, 2, 3, and 4 inhibited the edema formation by 53%, 63%, 54%, and 82%, respectively, at the third hour of the experiment. In the acetic acid-induced writhing test in mice, compounds 2 and 4 produced inhibition levels of 97% and 92%, respectively, while 3 displayed lower effect (75%), which was still higher than 1. The assayed compounds neither displayed activity in the cell migration test nor in the hot plate test.
doi_str_mv 10.1016/j.bmcl.2004.12.035
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67395141</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X04014957</els_id><sourcerecordid>67395141</sourcerecordid><originalsourceid>FETCH-LOGICAL-c384t-c2aceba8478c43025b12fab453df6867435ae4fce876a19b3de52a4e0a630db3</originalsourceid><addsrcrecordid>eNp9kM1u1DAUhS0EokPhBVggb6hgkWDHjpNIbFDFn1SJRbtAbKxr-6Z45NjFTkaaN-iaR-yTkNGM1B2ru7jfOTr6CHnNWc0ZVx-2tZlsqBvGZM2bmon2CdlwqWQlJGufkg0bFKv6Qf48Iy9K2TLGJZPyOTnjrerVwLoN-XW9j_NvLL5QiI4an0K69RYCBTv7nZ_3FHcQFph9ijSNNPjbCJGG9Z0iFuow-x06OuY00XcP93_fV3YxaHx8SZ6NEAq-Ot1zcvPl883lt-rqx9fvl5-uKit6OVe2AYsGetn1VgrWtIY3IxjZCjeuKzspWkA5Wuw7BXwwwmHbgEQGSjBnxDm5ONbe5fRnwTLryReLIUDEtBStOjG0XPIVbI6gzamUjKO-y36CvNec6YNQvdUHofogVPNGr0LX0JtT-2ImdI-Rk8EVeHsCoKzaxgzR-vLIKdkz1R-KPh45XFXsPGZdrMdo0fmMdtYu-f_t-Adt_ZXr</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67395141</pqid></control><display><type>article</type><title>Synthesis and biological activity evaluation of lignan lactones derived from (−)-cubebin</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Silva, Rosangela da ; de Souza, Gustavo H.B. ; da Silva, Ademar A. ; de Souza, Vanessa A. ; Pereira, Ana C. ; Royo, Vanesa de A. ; e Silva, Marcio L.A. ; Donate, Paulo M. ; de Matos Araújo, Ana L.S. ; Carvalho, José C.T. ; Bastos, Jairo K.</creator><creatorcontrib>Silva, Rosangela da ; de Souza, Gustavo H.B. ; da Silva, Ademar A. ; de Souza, Vanessa A. ; Pereira, Ana C. ; Royo, Vanesa de A. ; e Silva, Marcio L.A. ; Donate, Paulo M. ; de Matos Araújo, Ana L.S. ; Carvalho, José C.T. ; Bastos, Jairo K.</creatorcontrib><description>The anti-inflammatory and analgesic activities of three dibenzylbutyrolactone lignans obtained by partial synthesis starting from (−)-cubebin ( 1), which was isolated from the seeds of Piper cubeba, were evaluated using different animal models. The anti-inflammatory and analgesic effects of three dibenzylbutyrolactone lignans, (−)-hinokinin ( 2), (−)-6,6′-dinitrohinokinin ( 3), and (−)-6,6′-diaminohinokinin ( 4), obtained by partial synthesis from (−)-cubebin ( 1), were investigated using different animal models. It was observed that compounds ( 1) and ( 2) inhibited the edema formation in the rat paw edema assay at the same level and that all responses were dose dependent. Also, at the dose of 30 mg/kg, compounds 1, 2, 3, and 4 inhibited the edema formation by 53%, 63%, 54%, and 82%, respectively, at the third hour of the experiment. In the acetic acid-induced writhing test in mice, compounds 2 and 4 produced inhibition levels of 97% and 92%, respectively, while 3 displayed lower effect (75%), which was still higher than 1. The assayed compounds neither displayed activity in the cell migration test nor in the hot plate test.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2004.12.035</identifier><identifier>PMID: 15686907</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Analgesics ; Analgesics - chemical synthesis ; Analgesics - pharmacology ; Animals ; Anti-Inflammatory Agents - chemical synthesis ; Anti-Inflammatory Agents - pharmacology ; Anti-inflammatory and analgesic activities ; Biological and medical sciences ; Bones, joints and connective tissue. Antiinflammatory agents ; Cubebin ; Dose-Response Relationship, Drug ; Edema - drug therapy ; Lactones - chemical synthesis ; Lactones - pharmacology ; Lignan lactones ; Lignans - chemical synthesis ; Lignans - chemistry ; Lignans - pharmacology ; Medical sciences ; Neuropharmacology ; Pain Threshold - drug effects ; Pharmacology. Drug treatments ; Rats</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 2005-02, Vol.15 (4), p.1033-1037</ispartof><rights>2004 Elsevier Ltd</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c384t-c2aceba8478c43025b12fab453df6867435ae4fce876a19b3de52a4e0a630db3</citedby><cites>FETCH-LOGICAL-c384t-c2aceba8478c43025b12fab453df6867435ae4fce876a19b3de52a4e0a630db3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16480685$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15686907$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Silva, Rosangela da</creatorcontrib><creatorcontrib>de Souza, Gustavo H.B.</creatorcontrib><creatorcontrib>da Silva, Ademar A.</creatorcontrib><creatorcontrib>de Souza, Vanessa A.</creatorcontrib><creatorcontrib>Pereira, Ana C.</creatorcontrib><creatorcontrib>Royo, Vanesa de A.</creatorcontrib><creatorcontrib>e Silva, Marcio L.A.</creatorcontrib><creatorcontrib>Donate, Paulo M.</creatorcontrib><creatorcontrib>de Matos Araújo, Ana L.S.</creatorcontrib><creatorcontrib>Carvalho, José C.T.</creatorcontrib><creatorcontrib>Bastos, Jairo K.</creatorcontrib><title>Synthesis and biological activity evaluation of lignan lactones derived from (−)-cubebin</title><title>Bioorganic &amp; medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>The anti-inflammatory and analgesic activities of three dibenzylbutyrolactone lignans obtained by partial synthesis starting from (−)-cubebin ( 1), which was isolated from the seeds of Piper cubeba, were evaluated using different animal models. The anti-inflammatory and analgesic effects of three dibenzylbutyrolactone lignans, (−)-hinokinin ( 2), (−)-6,6′-dinitrohinokinin ( 3), and (−)-6,6′-diaminohinokinin ( 4), obtained by partial synthesis from (−)-cubebin ( 1), were investigated using different animal models. It was observed that compounds ( 1) and ( 2) inhibited the edema formation in the rat paw edema assay at the same level and that all responses were dose dependent. Also, at the dose of 30 mg/kg, compounds 1, 2, 3, and 4 inhibited the edema formation by 53%, 63%, 54%, and 82%, respectively, at the third hour of the experiment. In the acetic acid-induced writhing test in mice, compounds 2 and 4 produced inhibition levels of 97% and 92%, respectively, while 3 displayed lower effect (75%), which was still higher than 1. The assayed compounds neither displayed activity in the cell migration test nor in the hot plate test.</description><subject>Analgesics</subject><subject>Analgesics - chemical synthesis</subject><subject>Analgesics - pharmacology</subject><subject>Animals</subject><subject>Anti-Inflammatory Agents - chemical synthesis</subject><subject>Anti-Inflammatory Agents - pharmacology</subject><subject>Anti-inflammatory and analgesic activities</subject><subject>Biological and medical sciences</subject><subject>Bones, joints and connective tissue. Antiinflammatory agents</subject><subject>Cubebin</subject><subject>Dose-Response Relationship, Drug</subject><subject>Edema - drug therapy</subject><subject>Lactones - chemical synthesis</subject><subject>Lactones - pharmacology</subject><subject>Lignan lactones</subject><subject>Lignans - chemical synthesis</subject><subject>Lignans - chemistry</subject><subject>Lignans - pharmacology</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Pain Threshold - drug effects</subject><subject>Pharmacology. Drug treatments</subject><subject>Rats</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNp9kM1u1DAUhS0EokPhBVggb6hgkWDHjpNIbFDFn1SJRbtAbKxr-6Z45NjFTkaaN-iaR-yTkNGM1B2ru7jfOTr6CHnNWc0ZVx-2tZlsqBvGZM2bmon2CdlwqWQlJGufkg0bFKv6Qf48Iy9K2TLGJZPyOTnjrerVwLoN-XW9j_NvLL5QiI4an0K69RYCBTv7nZ_3FHcQFph9ijSNNPjbCJGG9Z0iFuow-x06OuY00XcP93_fV3YxaHx8SZ6NEAq-Ot1zcvPl883lt-rqx9fvl5-uKit6OVe2AYsGetn1VgrWtIY3IxjZCjeuKzspWkA5Wuw7BXwwwmHbgEQGSjBnxDm5ONbe5fRnwTLryReLIUDEtBStOjG0XPIVbI6gzamUjKO-y36CvNec6YNQvdUHofogVPNGr0LX0JtT-2ImdI-Rk8EVeHsCoKzaxgzR-vLIKdkz1R-KPh45XFXsPGZdrMdo0fmMdtYu-f_t-Adt_ZXr</recordid><startdate>20050215</startdate><enddate>20050215</enddate><creator>Silva, Rosangela da</creator><creator>de Souza, Gustavo H.B.</creator><creator>da Silva, Ademar A.</creator><creator>de Souza, Vanessa A.</creator><creator>Pereira, Ana C.</creator><creator>Royo, Vanesa de A.</creator><creator>e Silva, Marcio L.A.</creator><creator>Donate, Paulo M.</creator><creator>de Matos Araújo, Ana L.S.</creator><creator>Carvalho, José C.T.</creator><creator>Bastos, Jairo K.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20050215</creationdate><title>Synthesis and biological activity evaluation of lignan lactones derived from (−)-cubebin</title><author>Silva, Rosangela da ; de Souza, Gustavo H.B. ; da Silva, Ademar A. ; de Souza, Vanessa A. ; Pereira, Ana C. ; Royo, Vanesa de A. ; e Silva, Marcio L.A. ; Donate, Paulo M. ; de Matos Araújo, Ana L.S. ; Carvalho, José C.T. ; Bastos, Jairo K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c384t-c2aceba8478c43025b12fab453df6867435ae4fce876a19b3de52a4e0a630db3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Analgesics</topic><topic>Analgesics - chemical synthesis</topic><topic>Analgesics - pharmacology</topic><topic>Animals</topic><topic>Anti-Inflammatory Agents - chemical synthesis</topic><topic>Anti-Inflammatory Agents - pharmacology</topic><topic>Anti-inflammatory and analgesic activities</topic><topic>Biological and medical sciences</topic><topic>Bones, joints and connective tissue. Antiinflammatory agents</topic><topic>Cubebin</topic><topic>Dose-Response Relationship, Drug</topic><topic>Edema - drug therapy</topic><topic>Lactones - chemical synthesis</topic><topic>Lactones - pharmacology</topic><topic>Lignan lactones</topic><topic>Lignans - chemical synthesis</topic><topic>Lignans - chemistry</topic><topic>Lignans - pharmacology</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Pain Threshold - drug effects</topic><topic>Pharmacology. Drug treatments</topic><topic>Rats</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Silva, Rosangela da</creatorcontrib><creatorcontrib>de Souza, Gustavo H.B.</creatorcontrib><creatorcontrib>da Silva, Ademar A.</creatorcontrib><creatorcontrib>de Souza, Vanessa A.</creatorcontrib><creatorcontrib>Pereira, Ana C.</creatorcontrib><creatorcontrib>Royo, Vanesa de A.</creatorcontrib><creatorcontrib>e Silva, Marcio L.A.</creatorcontrib><creatorcontrib>Donate, Paulo M.</creatorcontrib><creatorcontrib>de Matos Araújo, Ana L.S.</creatorcontrib><creatorcontrib>Carvalho, José C.T.</creatorcontrib><creatorcontrib>Bastos, Jairo K.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Silva, Rosangela da</au><au>de Souza, Gustavo H.B.</au><au>da Silva, Ademar A.</au><au>de Souza, Vanessa A.</au><au>Pereira, Ana C.</au><au>Royo, Vanesa de A.</au><au>e Silva, Marcio L.A.</au><au>Donate, Paulo M.</au><au>de Matos Araújo, Ana L.S.</au><au>Carvalho, José C.T.</au><au>Bastos, Jairo K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and biological activity evaluation of lignan lactones derived from (−)-cubebin</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2005-02-15</date><risdate>2005</risdate><volume>15</volume><issue>4</issue><spage>1033</spage><epage>1037</epage><pages>1033-1037</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>The anti-inflammatory and analgesic activities of three dibenzylbutyrolactone lignans obtained by partial synthesis starting from (−)-cubebin ( 1), which was isolated from the seeds of Piper cubeba, were evaluated using different animal models. The anti-inflammatory and analgesic effects of three dibenzylbutyrolactone lignans, (−)-hinokinin ( 2), (−)-6,6′-dinitrohinokinin ( 3), and (−)-6,6′-diaminohinokinin ( 4), obtained by partial synthesis from (−)-cubebin ( 1), were investigated using different animal models. It was observed that compounds ( 1) and ( 2) inhibited the edema formation in the rat paw edema assay at the same level and that all responses were dose dependent. Also, at the dose of 30 mg/kg, compounds 1, 2, 3, and 4 inhibited the edema formation by 53%, 63%, 54%, and 82%, respectively, at the third hour of the experiment. In the acetic acid-induced writhing test in mice, compounds 2 and 4 produced inhibition levels of 97% and 92%, respectively, while 3 displayed lower effect (75%), which was still higher than 1. The assayed compounds neither displayed activity in the cell migration test nor in the hot plate test.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>15686907</pmid><doi>10.1016/j.bmcl.2004.12.035</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 2005-02, Vol.15 (4), p.1033-1037
issn 0960-894X
1464-3405
language eng
recordid cdi_proquest_miscellaneous_67395141
source ScienceDirect Freedom Collection 2022-2024
subjects Analgesics
Analgesics - chemical synthesis
Analgesics - pharmacology
Animals
Anti-Inflammatory Agents - chemical synthesis
Anti-Inflammatory Agents - pharmacology
Anti-inflammatory and analgesic activities
Biological and medical sciences
Bones, joints and connective tissue. Antiinflammatory agents
Cubebin
Dose-Response Relationship, Drug
Edema - drug therapy
Lactones - chemical synthesis
Lactones - pharmacology
Lignan lactones
Lignans - chemical synthesis
Lignans - chemistry
Lignans - pharmacology
Medical sciences
Neuropharmacology
Pain Threshold - drug effects
Pharmacology. Drug treatments
Rats
title Synthesis and biological activity evaluation of lignan lactones derived from (−)-cubebin
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T15%3A00%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20biological%20activity%20evaluation%20of%20lignan%20lactones%20derived%20from%20(%E2%88%92)-cubebin&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Silva,%20Rosangela%20da&rft.date=2005-02-15&rft.volume=15&rft.issue=4&rft.spage=1033&rft.epage=1037&rft.pages=1033-1037&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2004.12.035&rft_dat=%3Cproquest_cross%3E67395141%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c384t-c2aceba8478c43025b12fab453df6867435ae4fce876a19b3de52a4e0a630db3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=67395141&rft_id=info:pmid/15686907&rfr_iscdi=true